Several lines of evidence suggest a link between cocaine-primed craving and depressive symptomatology. The purpose of this study was to directly relate these two clinical phenomena. Thirty-three cocainedependent subjects were rated on the Hamilton Rating Scale for Depression (HRSD) at baseline and then administered an i.v. bolus of cocaine (0.2 mg/kg). Multiple regression analysis revealed that only the HRSD score was an independent predictor of cocaine-primed craving (F= 4.09; d.f. = 10,22; r=0.81, p< 0.003) when baseline spontaneous craving during early withdrawal, age, gender, frequency of use, time since last use, monetary expenditure on cocaine and the Addiction Severity Index Drug Composite Scores were considered. These data support the hypothesis that depressive symptomatology affects cocaine-primed craving and that this relationship is relatively specific to symptoms defined by the HRSD and is not seen with a number of other clinical and demographic variables.
American Psychiatric Association (1994), Diagnostic and statistical manual of mental disorders, 4th edn.American Psychiatric Association, Washington DC
2.
Ardnt I O, Dorozynsky L, Woody G E, McLellan A T, O’Brien C P (1992) Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry49: 888–893
3.
Avants S K, Margolin A, Kosten T R, Cooney N L (1995) Differences between responders and nonresponders to cocaine cues in the laboratory. Addict Behav20: 215–224
4.
Breiter H C, Rosen B R (1999) Functional magnetic resonance imaging of brain reward circuitry in the human. Ann NY Acad Sci877: 523–547
5.
Breiter H C, Gollub R L, Weisskoff R M, Kennedy D N, Makris N, Berke J D, Goodman J M, Kantor H L, Gastfriend D R, Riorden J P, Mathew R T, Rosen B R, Hyman S E (1997) Acute effects of cocaine on human brain activity and emotion. Neuron19: 591–611
6.
Carroll K M, Rounsaville B J, Gordon L T, Nich C, Jatlow P, Bisighini R M, Gawin F H (1994) Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry51: 177–187
7.
Carroll K M, Nich C, Rounsaville B J (1995) Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis183: 251–259
8.
Elman I, Karlsgodt K, Gastfriend D R (2001a) Gender differences in craving, mood and stress among non-treatment seeking individuals with cocaine dependence. Am J Drug Alcohol Abuse27: 193–202
9.
Elman I, Krause S, Karlsgodt K, Schoenfeld D A, Gollub R L, Breiter H C, Gastfriend D R (2001b) Clinical outcomes following cocaine infusion in non-treatment seeking individuals with cocaine dependence. Biol Psychiatry49: 533–535
10.
Faustman W O, Faull K F, Whiteford H A, Borchert C, Csernansky J G (1990) CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biol Psychiatry27: 311–318
11.
Fischman M W, Foltin R W, Nestadt G, Pearlson G D (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther253: 760–770
12.
Gardner E L (1999) The neurobiology and genetics of addiction: implications of the ‘Reward Deficiency Syndrome’ for theraputic strategies in chemical dependency. In Elster J (ed), Addictions: entries and exits. Russell Sage Foundation, New York
13.
Gawin F H, Kleber H D (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry43: 107–113
14.
Gawin F H, Kleber H D, Byck R, Rounsaville B J, Kosten T R, Jatlow P I, Morgan C (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry46: 117–121
15.
Gawin F H (2001) The scientific exegesis of desire: neuroimaging crack craving. Arch Gen Psychiatry 200158: 342–344
16.
Hommer D W (1999) Functional imaging of craving. Alcohol Res Health23: 187–196
17.
Jaffe J H, Cascella N G, Kumor K M, Sherer M A (1989) Cocaineinduced cocaine craving. Psychopharmacology97: 59–64
18.
Khantzian E J (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry142: 1259–1264
19.
Kilts C D, Schweitzer J B, Quinn C K, Gross R E, Raber T L, Muhammad F, Ely T D, Hoffman J M, Drexler K P (2001) Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry58: 334–341
20.
Koob G F, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology24: 97–129
21.
Kosten T R, Markou A, Koob G F (1998) Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis186: 737–745
22.
Margolin A, Kosten T R, Avants S K, Wilkins J, Ling W, Beckson M et al. (1995) A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend40: 125–131
23.
Markou A, Koob G F (1991) Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology4: 17–26
24.
Markou A, Weiss F, Gold L H, Caine S B, Schulteis G, Koob G F (1993) Animal models of drug craving. Psychopharmacology112: 163–182
25.
Markou A, Kosten T R, Koob G F (1998) Neurobiological similarities in depression and drug dependence: a selfmedication hypothesis. Neuropsychopharmacology18: 135–174
26.
McDowell D M, Levin F R, Seracini A M, Nunes E V (2000) Venlafaxine treatment of cocaine abusers with depressive disorders. Am J Drug Alcohol Abuse26: 25–31
27.
McLellan A T, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The Fifth edn of the Addiction Severity Index. J Subst Abuse Treat9: 199–213
28.
Nunes E V, McGrath P J, Quitkin F M, Ocepek-Welikson K, Stewart J W, Koenig T, Wager S, Klein D F (1995) Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend39: 185–195
29.
Rohsenow D J, Niaura R S, Childress A R, Abrams D B, Monti P M (1990) Cue reactivity in addictive behaviors: theoretical and treatment implications. In J Addict25: 957–993
30.
Schmitz J M, Stotts A L, Averill P M, Rothfleisch J M, Bailley S E, Sayre S L, Grabowski J (2000) Cocaine dependence with and without comorbid depression: a comparison of patient characteristics. Drug Alcohol Depend60: 189–198
31.
Schmitz J M, Averill P, Stotts AL, Moeller F G, Rhoades H M, Grabowski J (2001) Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend63: 207–214
32.
Schultz W, Dayan P, Montague P R (1997) A neural substrate of prediction and reward. Science275: 1593–1599
33.
Simpson D D, Joe G W, Fletcher B W, Hubbard R L, Anglin M D (1999) A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry56: 507–514
34.
Uslaner J, Kalechstein A, Richter T, Ling W, Newton T (1999) Association of depressive symptoms during abstinence with the subjective high produced by cocaine. Am J Psychiatry156: 1444–1446
35.
Wang G J, Volkow N D, Fowler J S, Cervany P, Hitzemann R J, Pappas N R, Wong C T, Felder C (1999) Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci64: 775–784
36.
Weinstein A, Feldtkeller B, Malizia A, Wilson S, Bailey J, Nutt D J (1998) Integrating the cognitive and physiological aspects of craving. J Psychopharmacol12: 31–38
37.
Weiss R D, Griffin M L, Mirin S M (1992) Drug abuse as selfmedication for depression: an empirical study. Am J Drug Alcohol Abuse18: 121–129
38.
Weiss R D, Griffin M L, Hufford C (1995) Craving in hospitalized cocaine abusers as a predictor of outcome. Am J Drug Alcohol Abuse21: 289–301
39.
Weiss R D, Griffin M L, Hufford C, Muenz L R, Najavits L M, Jansson S B, Kogan J, Thompson H J (1997) Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. Am J Addict6: 224–231
40.
Ziedonis D M, Kosten T R (1991a) Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull27: 337–343
41.
Ziedonis D M, Kosten T R (1991b) Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs23: 417–425
